Galapagos NV
GLPG
#5071
Rank
โ‚ฌ1.63 B
Marketcap
24,29ย โ‚ฌ
Share price
0.00%
Change (1 day)
-12.75%
Change (1 year)

Galapagos NV (GLPG) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : โ‚ฌ0.12 Billion

According to Galapagos NV's latest financial reports the company's total liabilities are โ‚ฌ0.12 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Galapagos NV - Total liabilities on balance sheet (from 2008 to 2026)

Total liabilities by year

Year Total liabilities Change
2024-12-31โ‚ฌ1.23 B-20.68%
2023-12-31โ‚ฌ1.56 B-29.28%
2022-12-31โ‚ฌ2.20 B-13.39%
2021-12-31โ‚ฌ2.54 B-16.33%
2020-12-31โ‚ฌ3.04 B-4.56%
2019-12-31โ‚ฌ3.19 B1317.53%
2018-12-31โ‚ฌ0.22 B-17.88%
2017-12-31โ‚ฌ0.27 B-15.51%
2016-12-31โ‚ฌ0.32 B318.81%
2015-12-31โ‚ฌ77.51 M20.49%
2014-12-31โ‚ฌ64.33 M-46.5%
2013-12-31โ‚ฌ0.12 B2.87%
2012-12-31โ‚ฌ0.11 B173.86%
2011-12-31โ‚ฌ42.67 M-6.11%
2010-12-31โ‚ฌ45.45 M30.49%
2009-12-31โ‚ฌ34.83 M0.96%
2008-12-31โ‚ฌ34.5 M-31.13%
2007-12-31โ‚ฌ50.09 M-13.78%
2006-12-31โ‚ฌ58.1 M184.45%
2005-12-31โ‚ฌ20.42 M289.38%
2004-12-31โ‚ฌ5.24 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ104.86 B 86,768.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚ฌ50.56 B 41,791.69%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚ฌ125.33 B 103,725.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ55.64 B 45,995.08%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
โ‚ฌ72.49 B 59,952.39%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ58.36 B 48,252.36%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚ฌ52.72 B 43,575.90%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
โ‚ฌ0.13 B 12.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚ฌ27.86 B 22,982.23%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel